Literature DB >> 28806363

Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.

Ish P Bhalla1, Elina A Stefanovics, Robert A Rosenheck.   

Abstract

OBJECTIVE: While research on substance abuse has largely focused on people who have a single substance use disorder (SUD), many people abuse multiple substances. Studies have yet to examine the distinctive characteristics of patients diagnosed with more than 1 SUD and how those with polysubstance use disorder (PSUD) differ from those with a single SUD.
METHODS: National Veterans Health Administration data from fiscal year 2012 were used to compare veterans diagnosed 1 SUD to veterans diagnosed with 2-3, and >3 SUDs on demographic characteristics, psychiatric and medical diagnoses, medical and psychiatric service utilization, and psychotropic medication fills. Comparisons of the 3 groups were based on bivariate and multiple logistic regression analyses.
RESULTS: Of the 472,624 veterans with at least 1 diagnosed SUD, 346,329 (73.2%) had 1 disorder, 113,598 (24.0%) had 2-3, and 12,715 (2.7%) had >3 SUDs. Veterans with higher levels of PSUD were more likely to be black and homeless, were more likely to have hepatic disease as well as schizophrenia, bipolar disorder, major depressive disorder, and personality disorders. Higher levels of PSUD were associated with greater use of psychiatric inpatient care, residential and rehabilitative treatment, and with multiple psychotropic medication prescription fills.
CONCLUSIONS: Veterans with PSUD have more severe problems along several dimensions and use more numerous and varied services than those with 1 SUD. This distinctive clinical profile warrants research to develop and evaluate methods for treating patients with complex multimorbid disorders that involve interactions between medical morbidity and psychosocial dysfunction.

Entities:  

Mesh:

Year:  2017        PMID: 28806363     DOI: 10.1097/MLR.0000000000000731

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  20 in total

1.  Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.

Authors:  Christine Timko; Xiaotong Han; Erin Woodhead; Alexandra Shelley; Michael A Cucciare
Journal:  J Stud Alcohol Drugs       Date:  2018-09       Impact factor: 2.582

2.  Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015.

Authors:  Taeho Greg Rhee; Somaia Mohamed; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

3.  Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Addiction       Date:  2019-07-25       Impact factor: 6.526

4.  Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  J Affect Disord       Date:  2019-04-08       Impact factor: 4.839

5.  Resting state functional connectivity in alcohol users and co-users of other substances.

Authors:  Vanessa Morris; Sabrina K Syan; James MacKillop; Michael Amlung
Journal:  Psychiatry Res Neuroimaging       Date:  2022-02-17       Impact factor: 2.493

6.  The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates.

Authors:  Ryan Bogdan; Arpana Agrawal; Alexander S Hatoum; Emma C Johnson; Sarah M C Colbert; Renato Polimanti; Hang Zhou; Raymond K Walters; Joel Gelernter; Howard J Edenberg
Journal:  Neuropsychopharmacology       Date:  2021-11-08       Impact factor: 8.294

7.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07

8.  Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Health Serv Res       Date:  2018-10-17       Impact factor: 3.402

9.  Comparison of opioid use disorder among male veterans and non-veterans: Disorder rates, socio-demographics, co-morbidities, and quality of life.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Am J Addict       Date:  2019-01-21

10.  Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: Results from the 2016 National Inpatient Sample.

Authors:  He Zhu; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.